MS
Mark Sabag sold $2M of TEVA stock
Mark Sabag, See "Remarks" of Teva Pharmaceutical Industries Ltd (TEVA), sold 44,710 shares of TEVA stock worth $2M, per an SEC Form 4 filed Nov 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Nov 12, 2026.
TEVA has moved +0.0% since the trade date, from $43.65 to $43.65 (Nov 12, 2026 close).
- Traded
- Nov 12, 2026
- Disclosed
- Nov 12, 2026
- Filing delay
- 0 days
- Price since
- +0.0%
- Role
- See "Remarks"
- Source
- SEC Form 4